Journal Information
Vol. 38. Issue. 5.September - October 2018
Pages 459-572
Share
Share
Download PDF
More article options
Vol. 38. Issue. 5.September - October 2018
Pages 459-572
Letter to the Editor
DOI: 10.1016/j.nefroe.2018.02.012
Open Access
Unmeasurable severe hypernatremia: A different way of using the calculated serum osmolality formula
Hipernatremia incalculable severa: una manera diferente de utilizar la fórmula de osmolaridad sérica
Visits
822
Aravindhan Arumugarajah, Christopher Webster, Luis M. Ortega
Corresponding author
lortega@ahn.org

Corresponding author.
Allegheny General Hospital, Division of Nephrology and Hypertension, 320 East North Avenue, Pittsburgh, PA 15212, United States
This item has received
822
Visits

Under a Creative Commons license
Article information
Full Text
Bibliography
Download PDF
Statistics
Figures (1)
Tables (1)
Table 1. Lab parameters during hospitalization.
Full Text
Dear Editor:

Hypernatremia is a common electrolyte disorder with increased morbidity and mortality, especially in elderly and critically ill patients. It is most frequently associated with free water losses, but it can also be induced by the administration of hypertonic saline or sodium bicarbonate.1,2 The mortality rates for critically ill patients with hypernatremia are as high as 50%.3 Symptoms from hypernatremia include lethargy, weakness, irritability, seizures, and are as severe as coma.4,5

A 59-year-old Caucasian female presented to the hospital with subarachnoid hemorrhage and severe intracranial hypertension (ICH). The patient required intubation for ventilator support, and started on vasopressors for hemodynamic support. She was also started on hypertonic (3%) saline as an adjunctive therapy for her ICH. On admission, her serum sodium was 141mEq/l. Over the next 4 days, despite hypertonic saline having been discontinued, the patient developed severe hypernatremia that was undetectable by the standard assay (ion specific electrode). Her serum sodium was measured as >180mEq/l. She also developed polyuria with a urine osmolality of 220mOsm/l, raising the possibility of diabetes insipidus. D5W was started for this patient in combination with scheduled doses of DDAVP to decrease her serum sodium slowly. We had to use the equation (Fig. 1) for serum osmolality to calculate the serum sodium, given the significantly elevated levels, to ensure proper correction. We recognized that the equation is an indirect marker for serum sodium determination, which incorporates blood urea nitrogen and serum glucose concentrations in its calculation. Her peak serum osmolality was 403mOsm/kg, and it was later lowered to 381mOsm/kg in a 24-h interval (Table 1). It was not until 30h into therapy that the serum sodium level became detectable at 173mEq/l, with a concomitant serum osmolality of 366mOsm/kg.

Fig. 1.

Serum osmolality calculator with algebraic modification.

(0.17MB).
Table 1.

Lab parameters during hospitalization.

Date  Serum osmolality  BUN  Glucose  Na+ (measured)  Na+ (calculated) 
5/10/17  394  196  >180  191 
5/10/17  403  220  >180  194 
5/10/17  395  126  >180  194 
5/10/17  387  169  >180  188 
5/10/17  387  194  >180  187 
5/11/17  381  197  >180  184 

5/10/17 determinations made during 5h intervals.

In conclusion, using the equation for serum osmolality is an indirect method to calculate the serum sodium level,6 which was especially useful in this patient with severe hypernatremia that was unmeasurable (>180mEq/l) with our standard assay. The applicability of the above mentioned formula allowed us to decreased the patients undetectable serum sodium close to normal range, preventing over-correction and under-correction.7,8 We estimate that the patient's serum sodium could have been as high as 194mEq/l.

Despite these limitations, we were able to indirectly monitor the patient's serum sodium level and adequately correct to goal.9,10 The patient survived her hospitalization and was discharged to a rehabilitation unit with improved serum sodium levels.

References
[1]
R.H. Sterns.
NEJM, 372 (2015), pp. 55-65
[2]
H.J. Adrogué, N.E. Madias.
Hypernatremia.
NEJM, 342 (2000), pp. 1493-1499
[3]
G. Lindner, G.-C. Funk, C. Schwarz, N. Kneidinger, A. Keider, B. Schneeweiss, et al.
Hypernatremia in the critically ill is an independent risk factor for mortality.
AJKD, 6 (2007), pp. 952-957
[4]
P.U. Feig, D.K. McCurdy.
The hypertonic state.
N Engl J Med, 297 (1977), pp. 1444-1454
[5]
J.G. Verbalis.
Brain volume regulation in response to changes in osmolality.
Neuroscience, 168 (2010), pp. 862-870
[6]
I.S. Edelman, J. Leibman, M.P. O’Meara, L.W. Birkenfeld.
Interrelations between serum sodium concentration, serum osmolarity and total exchangeable sodium, total exchangeable potassium, and total body water.
J Clin Invest, 37 (1958), pp. 1236-1256
[7]
H.M. Alshayeb, A. Showkat, F. Babar, T. Mangold, B.M. Wall.
Severe hypernatremia correction rate and mortality in hospitalized patients.
Am J Med Sci, 341 (2011), pp. 356-360
[8]
B.D. Rose.
New approach to disturbances in the plasma sodium concentration.
Am J Med, 81 (1986), pp. 1033-1040
[9]
A.P. Carlotti, D. Bohn, J.P. Mallie, M.L. Halperin.
Tonicity balance, and not electrolyte free water calculations, more accurately guides therapy for acute changes in natremia.
Intensive Care Med, 27 (2001), pp. 921-924
[10]
Y.H. Lien, J.I. Saphiro, L. Chan.
Effects of hypernatremia on organic brain osmoles.
J Clin Invest, 85 (1990), pp. 1427-1435
Copyright © 2018. Sociedad Española de Nefrología
Idiomas
Nefrología (English Edition)

Subscribe to our newsletter

Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

es en
Política de cookies Cookies policy
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.